MicroRNA Dysregulation in Cystic Fibrosis

Joint Authors

McKiernan, Paul J.
Greene, Catherine M.

Source

Mediators of Inflammation

Issue

Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2015-06-22

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases

Abstract EN

The cystic fibrosis lung is a complex milieu comprising multiple factors that coordinate its physiology.

MicroRNAs are regulatory factors involved in most biological processes and it is becoming increasingly clear that they play a key role in the development and manifestations of CF lung disease.

These small noncoding RNAs act posttranscriptionally to inhibit protein production.

Their involvement in the pathogenesis of CF lung disease stems from the fact that their expression is altered in vivo in the CF lung due to intrinsic and extrinsic factors; to date defective chloride ion conductance, endoplasmic reticulum stress, inflammation, and infection have been implicated in altering endogenous miRNA expression in this setting.

Here, the current state-of-the-art and biological consequences of altered microRNA expression in cystic fibrosis are reviewed.

American Psychological Association (APA)

McKiernan, Paul J.& Greene, Catherine M.. 2015. MicroRNA Dysregulation in Cystic Fibrosis. Mediators of Inflammation،Vol. 2015, no. 2015, pp.1-7.
https://search.emarefa.net/detail/BIM-1072407

Modern Language Association (MLA)

McKiernan, Paul J.& Greene, Catherine M.. MicroRNA Dysregulation in Cystic Fibrosis. Mediators of Inflammation No. 2015 (2015), pp.1-7.
https://search.emarefa.net/detail/BIM-1072407

American Medical Association (AMA)

McKiernan, Paul J.& Greene, Catherine M.. MicroRNA Dysregulation in Cystic Fibrosis. Mediators of Inflammation. 2015. Vol. 2015, no. 2015, pp.1-7.
https://search.emarefa.net/detail/BIM-1072407

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1072407